Related Experiment Video
Updated: Mar 25, 2026

Peptide-derived Method to Transport Genes and Proteins Across Cellular and Organellar Barriers in Plants
Published on: December 16, 2016
Mechanistic study of plasmid DNA delivery by Magainin 2-derived stapled peptides
Motoharu Hirano1, Yuki Takechi-Haraya2, Yasuhiro Abe3
1Graduate School of Medical Life Science, Yokohama City University, 1-7-29 Yokohama, Kanagawa 230-0045, Japan; Division of Organic Chemistry, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki, Kanagawa 210-9501, Japan.
Abstract:
In this study, the mechanism of the plasmid DNA (pDNA) delivery system using Magainin 2-derived stapled peptides (st7-5 and st7-5_R) was analysed. The effect of different cationic residues (Lys and Arg) on the stability and intracellular transport efficiency of the peptide/pDNA complex was assessed, with both peptides forming stable α-helical structures under neutral conditions and st7-5_R showing higher helical strength under acidic conditions. Agarose gel shift assays and PicoGreen staining showed that both peptides formed complete complexes at N/P ratios of 1.5-2 and protected pDNA from nucleases. However, in the presence of heparin sulfate, the st7-5_R/pDNA complex maintained higher stability than the st7-5/pDNA complex. Interaction analysis with lipid membranes indicated that st7-5 with Lys residues interacted strongly at pH 7.4 and st7-5_R with Arg residues at pH 5.5, suggesting that st7-5_R was highly capable of facilitating its escape from endosomes. The Förster resonance energy transfer (FRET) signal observed by confocal laser scanning microscopy (CLSM) indicated that the st7-5_R/pDNA complex disintegrated over time after intracellular introduction, releasing the encapsulated pDNA into the cell. These results indicate that Magainin 2-derived stapled peptides are promising carriers for efficient intracellular nucleic acid delivery, especially st7-5_R with its excellent stability and delivery efficiency. The findings of this study will contribute to the design of drug delivery system carrier peptides and the improvement of nucleic acid therapeutics.

